Legal & General Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $683M | Buy |
9,515,723
+206,541
| +2% | +$15.9M | 0.16% | 115 |
|
|
2025
Q4 | $739M | Buy |
9,309,182
+31,249
| +0.3% | +$2.46M | 0.16% | 104 |
|
|
2025
Q3 | $699M | Buy |
9,277,933
+294,891
| +3% | +$20.2M | 0.16% | 112 |
|
|
2025
Q2 | $620M | Sell |
8,983,042
-396,118
| -4% | -$26M | 0.15% | 122 |
|
|
2025
Q1 | $635M | Buy |
9,379,160
+176,256
| +2% | +$10.5M | 0.17% | 109 |
|
|
2024
Q4 | $413M | Sell |
9,202,904
-200,914
| -2% | -$11.3M | 0.11% | 178 |
|
|
2024
Q3 | $591M | Buy |
9,403,818
+189,615
| +2% | +$11.1M | 0.16% | 123 |
|
|
2024
Q2 | $544M | Sell |
9,214,203
-522,606
| -5% | -$32.7M | 0.15% | 127 |
|
|
2024
Q1 | $777M | Sell |
9,736,809
-119,498
| -1% | -$9.13M | 0.22% | 86 |
|
|
2023
Q4 | $778M | Buy |
9,856,307
+254,354
| +3% | +$18.1M | 0.24% | 79 |
|
|
2023
Q3 | $670M | Sell |
9,601,953
-293,403
| -3% | -$20.8M | 0.23% | 83 |
|
|
2023
Q2 | $684M | Buy |
9,895,356
+402,716
| +4% | +$28.7M | 0.22% | 86 |
|
|
2023
Q1 | $705M | Buy |
9,492,640
+74,348
| +0.8% | +$6.23M | 0.25% | 78 |
|
|
2022
Q4 | $878M | Sell |
9,418,292
-429,367
| -4% | -$41.4M | 0.34% | 55 |
|
|
2022
Q3 | $939M | Sell |
9,847,659
-473,501
| -5% | -$46.9M | 0.37% | 46 |
|
|
2022
Q2 | $956M | Buy |
10,321,160
+220,516
| +2% | +$21.5M | 0.34% | 53 |
|
|
2022
Q1 | $1.02B | Buy |
10,100,644
+690,854
| +7% | +$72.6M | 0.31% | 56 |
|
|
2021
Q4 | $971M | Sell |
9,409,790
-91,573
| -1% | -$8.46M | 0.29% | 58 |
|
|
2021
Q3 | $806M | Buy |
9,501,363
+129,808
| +1% | +$10.9M | 0.26% | 74 |
|
|
2021
Q2 | $782M | Buy |
9,371,555
+563,402
| +6% | +$46.1M | 0.26% | 73 |
|
|
2021
Q1 | $663M | Sell |
8,808,153
-321,435
| -4% | -$23.4M | 0.25% | 79 |
|
|
2020
Q4 | $624M | Buy |
9,129,588
+206,410
| +2% | +$13.4M | 0.24% | 76 |
|
|
2020
Q3 | $521M | Buy |
8,923,178
+156,129
| +2% | +$9.71M | 0.23% | 81 |
|
|
2020
Q2 | $570M | Sell |
8,767,049
-1,388
| -0% | -$87.4K | 0.28% | 68 |
|
|
2020
Q1 | $521M | Buy |
8,768,437
+469,515
| +6% | +$31.3M | 0.3% | 65 |
|
|
2019
Q4 | $617M | Buy |
8,298,922
+294,915
| +4% | +$20.7M | 0.29% | 67 |
|
|
2019
Q3 | $505M | Sell |
8,004,007
-200,629
| -2% | -$11.9M | 0.27% | 75 |
|
|
2019
Q2 | $447M | Sell |
8,204,636
-110,409
| -1% | -$5.95M | 0.24% | 85 |
|
|
2019
Q1 | $448M | Buy |
8,315,045
+1,009,205
| +14% | +$62.3M | 0.26% | 81 |
|
|
2018
Q4 | $479M | Buy |
7,305,840
+1,677,859
| +30% | +$125M | 0.37% | 50 |
|
|
2018
Q3 | $443M | Buy |
5,627,981
+43,405
| +0.8% | +$3.1M | 0.32% | 63 |
|
|
2018
Q2 | $359M | Sell |
5,584,576
-18,421
| -0.3% | -$1.21M | 0.28% | 76 |
|
|
2018
Q1 | $349M | Sell |
5,602,997
-350,666
| -6% | -$25.2M | 0.27% | 80 |
|
|
2017
Q4 | $432M | Sell |
5,953,663
-101,664
| -2% | -$7.39M | 0.31% | 64 |
|
|
2017
Q3 | $492M | Buy |
6,055,327
+468,024
| +8% | +$37M | 0.37% | 52 |
|
|
2017
Q2 | $450M | Buy |
5,587,303
+281,632
| +5% | +$22.2M | 0.36% | 49 |
|
|
2017
Q1 | $416M | Buy |
5,305,671
+268,160
| +5% | +$21.4M | 0.35% | 54 |
|
|
2016
Q4 | $398M | Sell |
5,037,511
-45,134
| -0.9% | -$3.65M | 0.37% | 52 |
|
|
2016
Q3 | $452M | Buy |
5,082,645
+190,034
| +4% | +$17.9M | 0.46% | 42 |
|
|
2016
Q2 | $468M | Sell |
4,892,611
-68,525
| -1% | -$6.83M | 0.49% | 41 |
|
|
2016
Q1 | $515M | Buy |
4,961,136
+92,196
| +2% | +$8.96M | 0.57% | 37 |
|
|
2015
Q4 | $476M | Sell |
4,868,940
-167,318
| -3% | -$16.4M | 0.54% | 38 |
|
|
2015
Q3 | $486M | Buy |
5,036,258
+267,020
| +6% | +$28.1M | 0.59% | 34 |
|
|
2015
Q2 | $500M | Buy |
4,769,238
+149,652
| +3% | +$15.3M | 0.59% | 34 |
|
|
2015
Q1 | $477M | Sell |
4,619,586
-166,101
| -3% | -$16.8M | 0.57% | 35 |
|
|
2014
Q4 | $461M | Sell |
4,785,687
-228,089
| -5% | -$20.1M | 0.54% | 34 |
|
|
2014
Q3 | $399M | Sell |
5,013,776
-315,050
| -6% | -$24.8M | 0.48% | 41 |
|
|
2014
Q2 | $402M | Sell |
5,328,826
-157,661
| -3% | -$11.9M | 0.47% | 40 |
|
|
2014
Q1 | $411M | Sell |
5,486,487
-177,453
| -3% | -$12.5M | 0.5% | 38 |
|
|
2013
Q4 | $405M | Sell |
5,663,940
-100,231
| -2% | -$6.44M | 0.49% | 41 |
|
|
2013
Q3 | $327M | Buy |
5,764,171
+73,072
| +1% | +$4.35M | 0.43% | 49 |
|
|
2013
Q2 | $325M | Buy |
+5,691,099
| New | +$330M | 0.45% | 45 |
|
Other funds holding CVS
VCM
VPM
Legal & General Group's CVS Position: Q1 2026 in Review
Legal & General Group increased its CVS Health (CVS) stake by 2.2% in Q1 2026, buying an estimated $15.9M and bringing the position to 9,515,723 shares worth $683M. The position accounts for 0.16% of the portfolio, ranked #115.
Legal & General Group first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.02B in Q1 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Legal & General Group held 9,515,723 shares of CVS Health worth $683M as of Q1 2026.
- Legal & General Group bought 206,541 CVS Health shares in Q1 2026, an estimated $15.9M.
- CVS Health made up 0.16% of Legal & General Group's portfolio in Q1 2026, its #115 holding.
- Legal & General Group first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Legal & General Group's CVS Health position peaked at $1.02B in Q1 2022.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.